Validity of Osteoprotegerin and Receptor Activator of NF-κB Ligand for the Detection of Bone Metastasis in Breast Cancer.
about
Validity of Osteoprotegerin and Receptor Activator of NF-κB Ligand for the Detection of Bone Metastasis in Breast Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Validity of Osteoprotegerin an ...... e Metastasis in Breast Cancer.
@en
Validity of Osteoprotegerin an ...... e Metastasis in Breast Cancer.
@nl
type
label
Validity of Osteoprotegerin an ...... e Metastasis in Breast Cancer.
@en
Validity of Osteoprotegerin an ...... e Metastasis in Breast Cancer.
@nl
prefLabel
Validity of Osteoprotegerin an ...... e Metastasis in Breast Cancer.
@en
Validity of Osteoprotegerin an ...... e Metastasis in Breast Cancer.
@nl
P2093
P1433
P1476
Validity of Osteoprotegerin an ...... ne Metastasis in Breast Cancer
@en
P2093
Gamal A Elfar
Laila A Eissa
Mohamed A Ebrahim
P304
P356
10.3727/096504016X14768398678750
P577
2016-10-26T00:00:00Z